Skip to evidence report

IPSC.mesodermal_primed: Studies — page 6

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 1,329 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 5,001–6,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for IPSC.mesodermal_primed
#Trait / studyIndividual trait IDMean IC score
5001Breast cancer (PheCode 174)GCST904356001.78
5002Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T167ECGU0001671.78
5003Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T396ECGA0003961.78
5004IDP dMRI TBSS ICVF Cingulum hippocampus RGCST900043631.77
5005IGSF8/NECTIN2 ratioGCST903151401.77
5006Right-hemisphere control network to right-hemisphere default mode network white-matter structural connectivityGCST903028351.77
5007aparc-Desikan lh area lingualGCST900030851.77
5008triglyceride (minimum, inv-norm transformed)GCST904764371.77
5009Abdominal aortic calcification levelsGCST901346141.76
5010Operative procedures - Fibreoptic endoscopic snare resection of lesion of colon | Summary OperationsUKBB000005791.76
5011COMP/DPP4 ratioGCST903141881.76
5012Benign neoplasm: Sigmoid colonFING000002031.76
5013Principal component-derived dietary pattern 27GCST901330321.76
5014Omega-6 fatty acids to total fatty acids percentageGCST905025441.76
5015PALM2 levelsGCST904701521.76
5016Multiple myeloma and malignant plasma cell neoplasms (controls excluding all cancers)FING000008431.75
5017IDP dMRI TBSS L3 Inferior cerebellar peduncle RGCST900041811.75
5018Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T184ECGU0001841.75
5019Free Cholesterol to Total Lipids in Large LDL percentageGCST904980001.75
5020Systolic blood pressureGCST904727811.75
5021Total bilirubin levels (UKB data field 30840)GCST904681041.75
5022Cholesterol in Large LDLGCST904979231.75
5023hemoglobin (mean, inv-norm transformed)GCST904753761.75
5024CCL28/PDGFB ratioGCST903136951.75
5025Remnant cholesterol (non-HDL, non-LDL -cholesterol)GCST904993401.74
5026Saturated fatty acids levels (UKB data field 23448)GCST902695451.74
5027Concentration of large LDL particlesGCST904980371.74
5028Phosphatidylethanolamine_35:2_[M-H]1- levelsGCST900602601.74
5029PDLIM7/PLA2G4A ratioGCST903156371.74
5030Osteoarthrosis NOS | musculoskeletalUKBB000005971.74
5031REST UKBBICA NET100 1212GCST903870661.74
5032Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T180ECGA0001801.74
5033Waist-to-hip ratio adjusted for BMIGCST900200251.74
5034IDP T1 FAST ROIs R mid front gyrusGCST900024581.73
5035Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T185ECGU0001851.73
5036Main speciality of consultant (recoded) - General surgery | Summary AdministrationUKBB000004171.73
5037Milk chocolate likingGCST900948011.73
5038Cholesteryl Esters in Small HDLGCST904993861.73
5039Frozen shoulderGCST900005131.73
5040DTI TBSS L3 Cingulum hippocampus RGCST903845601.73
5041Triacylglycerol_52:5_[M+NH4]1+ levelsGCST900605061.73
5042GUSB levelsGCST904694211.72
5043aseg lh intensity CaudateGCST900037691.72
5044HMBS/UBAC1 ratioGCST903150661.72
5045ThalamNuclei lh volume PfGCST900027221.72
5046Recent feelings or nervousness or anxiety | AnxietyUKBB000007411.72
5047Free cholesterol to total lipids ratio in IDLGCST900928361.72
5048Benign lipomatous neoplasmFING000001461.72
5049CNTN1/EGFR ratioGCST903141621.72
5050CCN1/DNAJB1 ratioGCST903137091.72
5051Urine 16a-hydroxy DHEA 3-sulfate levels in chronic kidney diseaseGCST902643291.72
5052SSC5D levelsGCST904707481.72
5053Arterial embolism and thrombosis of lower extremity arteryFING000001061.72
5054IDP dMRI TBSS L3 Cerebral peduncle RGCST900041851.71
5055DTI TBSS L2 External capsule RGCST903845081.71
5056aseg lh intensity Thalamus-ProperGCST900037681.71
5057ENO1 levelsGCST904691091.71
5058CPXM1/HBEGF ratioGCST903142191.71
5059CDH1 levelsGCST904686701.71
5060KITLG levelsGCST902748331.71
5061Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T405ECGA0004051.71
5062Been in a confiding relationship as an adult | Traumatic eventsUKBB000000881.71
5063LCAT levelsGCST904697451.71
5064IDP T1 FAST ROIs V cerebellum crus IIGCST900025731.70
5065WAS levelsGCST904710711.70
5066TNFRSF11B levelsGCST900120021.70
5067CPA1/CTRC ratioGCST903142041.70
5068GLOD4/HSPA1A ratioGCST903149371.70
5069DTI TBSS FA Posterior thalamic radiation LGCST903844091.70
5070Diacylglycerol_36:1_[M+H-H2O]1+ levelsGCST900601931.70
5071X-21829 levelsGCST902005851.70
5072Subarachnoid haemorrhageFING000013391.70
5073Nontoxic nodular goiter (PheCode 241)GCST904756381.70
5074GYS1/PPP1R2 ratioGCST903150011.70
5075Conditional arithmetic | Fluid intelligence / reasoningUKBB000001451.70
5076Free Cholesterol to Total Lipids in Very Small VLDL percentageGCST905007911.70
5077MED18/SMAD1 ratioGCST903154131.70
5078C1RL levelsGCST904684921.69
5079HYOU1/ROR1 ratioGCST903151041.69
5080Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T423ECGU0004231.69
5081X-26109 levelsGCST902006711.69
5082AmygNuclei rh volume Central-nucleusGCST900026621.69
50832s,3R-dihydroxybutyrate levelsGCST901998821.69
5084Reticulocyte fraction of red cellsGCST0046191.69
5085Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T183ECGA0001831.68
5086CTSZ/HSPG2 ratioGCST903143181.68
5087HydrocephalusFING000006281.68
5088Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T411ECGA0004111.68
5089Aspartate aminotransferase (AST, maximum, inv-norm transformed)GCST904751181.68
5090IDP dMRI ProbtrackX FA ar lGCST900039251.68
5091Triglycerides to Total Lipids in IDL percentageGCST904976761.68
5092Other specified cardiac dysrhythmias (PheCode 427.3)GCST904759751.68
5093Free Cholesterol in LDLGCST904983861.68
5094FSTL3 levelsGCST904692721.68
5095Phosphatidylcholine_34:2_[M+H]1+/Phosphatidylethanolamine_37:2_[M+H]1+/Phosphatidate_39:3_[M+NH4]1+ levelsGCST900603031.67
5096AmygNuclei rh volume Basal-nucleusGCST900026591.67
5097HydroceleFING000006271.67
5098Total esterified cholesterol levelsGCST900929861.67
5099Total lipids in very large VLDLGCST905006141.67
5100aparc-a2009s rh volume S-oc-middle+LunatusGCST900030551.67
5101Degree of unsaturationGCST905027491.67
5102Hemoglobin concentrationGCST900023101.67
5103Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T13ECGU0000131.67
5104DTI TBSS L2 Superior fronto-occipital fasciculus LGCST903845191.67
5105Abnormal movement (PheCode 350)GCST904758401.66
5106DLL4 levelsGCST904690051.66
5107Red cell distribution widthGCST900259881.66
5108Cholesteryl Esters to Total Lipids in Large LDL percentageGCST904979671.66
5109Total cholesterol levelsGCST900929851.66
5110Seminoma of testis, excluding all cancers (controls excluding all cancers)FING000012891.66
5111HYOU1/THBD ratioGCST903151061.66
5112Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T464ECGA0004641.66
5113Multi-trait sum scoreGCST902701171.66
5114IDP dMRI ProbtrackX ISOVF slf lGCST900045461.66
5115Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T166ECGU0001661.66
5116Aneurysms, operations, SAHFING000000851.66
5117aparc-pial lh area lateralorbitofrontalGCST900031521.65
5118Cooked vegetable intake | DietUKBB000001471.65
5119AGRN/BTN2A1 ratioGCST903131991.64
5120GRAP2/MAP4K5 ratioGCST903149821.64
5121Tetradecadienedioate (C14:2-DC) metabolite levelGCST906162751.64
5122IL18BP/ROR1 ratioGCST903151551.64
5123DTI autoptx L3 cgc r tractGCST903851981.64
5124CD55 levelsGCST904686371.64
5125Light smokers, at least 100 smokes in lifetime | SmokingUKBB000004071.64
5126DOK2/GRAP2 ratioGCST903145311.64
5127Dupuytren's diseaseGCST903012521.64
5128X-21364 levelsGCST902005661.64
5129NEO1 levelsGCST904700291.64
5130Triglycerides to Total Lipids in Small LDL percentageGCST904997261.64
5131CALCOCO1/CASP3 ratioGCST903135961.64
5132Obstructed labour due to maternal pelvic abnormalityFING000008991.63
5133Hearing aid useGCST900447741.63
5134Diastolic blood pressure (BMI unadjusted)GCST903351641.63
5135Cholesterol levels in chylomicrons and extremely large VLDLGCST905009181.63
5136Coronary artery calcificationGCST905030741.63
5137Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T399ECGA0003991.63
5138LifespanGCST905518841.63
5139Neutrophil countGCST900187481.63
5140Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T159ECGU0001591.63
5141Concentration of LDL particlesGCST904984131.63
5142T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 22)GCST903208411.63
5143Cancer of bladder (PheCode 189.2)GCST904755981.63
5144Migraine without aura and triptan purchasesFING000008221.62
5145Types of physical activity in last 4 weeks - Other exercises (eg: swimming, cycling, keep fit, bowling) | Physical activityUKBB000008731.62
5146Right subiculum volume (body)GCST902679801.62
5147AMBP/HYOU1 ratioGCST903132551.62
5148Chronic obstructive pulmonary disease in never smokersGCST900165891.62
5149Triglycerides to Total Lipids in Very Small VLDL percentageGCST905009001.62
5150AIFM1/PLXNA4 ratioGCST903132201.62
5151SCGB3A2 levelsGCST904705431.62
5152Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T245ECGU0002451.62
5153IDP dMRI TBSS ISOVF Superior corona radiata RGCST900045011.61
5154DYNLL1 levelsGCST902409841.61
5155HematocritGCST900023051.61
5156QC tfMRI-to-T1 linear alignment discrepancyGCST900063541.61
5157DTI autoptx L2 atr l tractGCST903851681.60
5158Cholesterol in very large VLDL (UKB data field 23491)GCST902695881.60
5159T1 FreeSurfer DK rh fusiform volumeGCST903857631.60
5160Medication use (calcium channel blockers)GCST900187671.60
5161aparc-a2009s rh thickness G-temporal-middleGCST900037141.60
5162Cholesterol levels in very large VLDLGCST900930161.60
5163Acceptance of an invitation to wear a physical activity monitorGCST900127911.60
5164NELL1 levelsGCST904700261.60
5165TIMP3/ZBTB16 ratioGCST903159211.59
5166Pulmonary heart disease (PheCode 415)GCST904759421.59
5167Total cholesterol levelsGCST902396751.59
5168Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T280ECGU0002801.59
5169ADAM23 levelsGCST904682191.59
5170Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T429ECGU0004291.59
5171Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T420ECGU0004201.59
5172Total lipids in large VLDLGCST904982161.59
5173Triglyceride levels in medium VLDLGCST900929261.59
5174IDP dMRI ProbtrackX FA cst rGCST900039341.59
5175IDP dMRI ProbtrackX L1 cgc rGCST900042511.59
5176DTI autoptx L1 ptr r tractGCST903851591.59
5177SERPINA12 levelsGCST904705811.59
5178NECTIN2/SDC1 ratioGCST903155291.59
5179APOA1 levelsGCST904971191.59
5180C1R levelsGCST904684931.58
5181Overweight, obesity and other hyperalimentation (PheCode 278)GCST904757591.58
5182Free cholesterol levels in large VLDLGCST900928721.58
5183Cholesteryl Esters to Total Lipids in Very Small VLDL percentageGCST905007541.58
5184Suicide or other Intentional self-harmFING000013451.58
5185F-seafood liking (derived food-liking factor)GCST900948361.58
5186IDP dMRI ProbtrackX ICVF cgc rGCST900043801.58
5187Mean arterial pressure (BMI unadjusted)GCST903351681.58
5188Cholesterol to Total Lipids in Small LDL percentageGCST904995691.58
5189MYOC/RGMB ratioGCST903155081.57
5190Mean corpuscular hemoglobinGCST0046301.57
5191BCAN/MOG ratioGCST903134801.57
5192CD300C/LRRC25 ratioGCST903137901.57
5193COL1A1/SOST ratioGCST903141721.57
5194CD58/MEGF10 ratioGCST903138531.57
5195INSL5 levelsGCST904696221.57
5196Do you currently smoke cigarettes?GCST904763881.57
5197IDP T1 FAST ROIs R parietal operc cortexGCST900025361.57
5198Colon polypsGCST904753191.57
5199Triglyceride levels in small LDLGCST900929661.56
5200Docosahexaenoic acid to total fatty acids percentage (UKB data field 23457)GCST902695541.56
5201Non-allergic asthma (mode) (more control exclusions)FING000008691.56
5202ATXN10/CASP10 ratioGCST903133961.56
5203X-12063 levelsGCST902436871.56
5204Cholesterol to total lipids ratio in large VLDLGCST900928691.56
5205FABP5/PPCDC ratioGCST903147631.56
5206Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T279ECGU0002791.56
5207IL31RA levelsGCST904695891.56
5208aparc-Desikan rh thickness postcentralGCST900035001.56
5209Left-hemisphere limbic network to right-hemisphere dorsal attention network white-matter structural connectivityGCST903027311.56
5210Intra-ocular pressure, Goldmann-correlated (right) | Intraocular pressureUKBB000003771.56
5211Leucine levelsGCST900928911.56
5212Fractured bone site(s) - Other bones | Medical conditionsUKBB000002561.56
5213Plasma methylsuccinate levels in chronic kidney diseaseGCST902655061.55
5214SMAD5 levelsGCST904706781.55
5215Triglycerides in HDLGCST904974641.55
5216Pain in limbFING000011381.54
5217Phospholipids in small HDLGCST904994831.54
5218Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T278ECGU0002781.54
5219MSTN levelsGCST904699531.54
5220Attention deficit hyperactivity disorder (adjusted for age, sex)GCST902751471.54
5221COPDFING000003501.54
5222CA2/HMBS ratioGCST903135791.54
5223Right-hemisphere visual network to right-hemisphere somatomotor network white-matter structural connectivityGCST903027751.54
5224AGRN/CRIM1 ratioGCST903132001.54
5225CPM levelsGCST902405981.53
5226PDLIM7/SRC ratioGCST903156391.53
5227Alanine levelsGCST0036661.53
5228CETN3 levelsGCST904687221.53
5229AnaemiasFING000000821.53
5230IDP dMRI TBSS L2 Cerebral peduncle RGCST900041371.53
5231Tense / 'highly strung' | Mental healthUKBB000008151.53
5232KIFBP/LYN ratioGCST903152461.53
5233aparc-a2009s lh thickness S-cingul-MarginalisGCST900036481.53
5234Proline levelsGCST902434571.53
5235DTI TBSS L3 Superior corona radiata RGCST903845481.53
5236PRDX3 levelsGCST904703171.52
5237T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 81)GCST903206441.52
5238ADAMTS15 levelsGCST904682231.52
5239Triglycerides in VLDLGCST905002951.52
5240DepressionGCST0037691.52
5241Phospholipids in HDLGCST904974301.52
5242Lysoalkylphosphatidylcholine (O-22:0) levelsGCST900241951.51
5243APOB levelsGCST904971371.51
5244Essential hypertension (PheCode 401.1)GCST904759221.51
5245Forced expiratory volume in 1-second (FEV1), predicted percentage | SpirometryUKBB000002531.51
5246COL6A3/COLEC12 ratioGCST903141731.51
5247CD300E/LILRA5 ratioGCST903137981.51
5248Coffee type: Decaffeinated coffee (any type) (UKB data field 1508_1)GCST901329741.51
5249Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T182ECGU0001821.51
5250Benign neoplasm: Adrenal glandFING000001641.51
5251Cholesterol to Total Lipids in Medium LDL percentageGCST904987141.51
5252Docosahexaenoic acid to total fatty acids percentageGCST905022691.50
5253Free cholesterol in small LDLGCST904996201.50
5254Alpha-hydroxyisovalerate levelsGCST901997361.50
5255IDP dMRI TBSS L3 Retrolenticular part of internal capsule LGCST900041921.50
5256Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T393ECGA0003931.50
5257Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T176ECGA0001761.49
5258DementiaFING000003911.49
5259Free Cholesterol to Total Lipids in Medium LDL percentageGCST904987831.49
5260PSME2/RBKS ratioGCST903157371.49
5261Concentration of small LDL particlesGCST904996601.49
5262Hypertensive heart and/or renal disease (PheCode 401.2)GCST904759241.49
5263HippSubfield rh volume CA1-bodyGCST900026921.49
5264IDP dMRI TBSS L2 Pontine crossing tractGCST900041241.49
5265T1 FreeSurfer DKT rh pericalcarine areaGCST903843051.49
5266PCDH17/PTPRM ratioGCST903156031.49
5267aparc-a2009s rh volume S-oc-temp-med+LingualGCST900030591.49
5268AOC3 levelsGCST904683221.48
5269wg lh intensity-contrast insulaGCST900038261.48
5270MANF/PTPN6 ratioGCST903153661.48
5271Invitation to complete online 24-hour recall dietary questionnaire, acceptance | Online follow-up - Diet by 24-hour recallUKBB000003781.48
5272Cholesterol to Total Lipids in Medium HDL percentageGCST904985191.48
5273EDAR/TACC3 ratioGCST903145891.48
5274HippSubfield rh volume subiculum-bodyGCST900026911.48
5275Type 2 diabetes, wide definitionFING000013831.48
5276Cancer code, self-reported: prostate cancer (UKB data field 20001_1044)GCST900419051.48
5277Chronic hepatitis C infectionGCST900185851.48
5278Left-hemisphere visual network to caudate white-matter structural connectivityGCST903026631.48
5279Fractured/broken bones in last 5 years | Medical conditionsUKBB000002581.48
5280Left ventricular stroke volumeGCST902681301.47
5281Acetate levels (UKB data field 23475)GCST902695721.47
5282Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T406ECGA0004061.47
5283Omega-6 fatty acid levelsGCST905021001.47
5284Erectile dysfunctionGCST0069561.47
5285Triglycerides to Total Lipids in Medium LDL percentageGCST904988851.47
5286CA2/TGM2 ratioGCST903135821.47
5287Left hippocampal volume (body)GCST902679481.47
5288aseg lh intensity PutamenGCST900037701.47
5289IGFBP6 levelsGCST904695311.47
5290GASK1A levelsGCST904693061.47
5291T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 43)GCST903206061.46
5292CD74/IL18BP ratioGCST903138921.46
5293Congenital lactase deficiencyFING000003291.46
5294Daytime napGCST0114941.46
5295GRP levelsGCST904694061.46
5296Myocardial infarctionGCST900186571.46
5297BA-exvivo lh thickness MTGCST900035241.46
5298SOST levelsGCST904707111.46
5299CDKN1A/YES1 ratioGCST903139801.46
5300CDKN1A/DAB2 ratioGCST903139671.46
5301Fruit likingGCST900947661.46
5302MAVS/PPP1R9B ratioGCST903153931.45
5303Left-hemisphere salience/ventral attention network to right-hemisphere somatomotor network white-matter structural connectivityGCST903027131.45
5304Principal component-derived dietary pattern 14GCST901330191.45
5305MINPP1 levelsGCST902419781.45
5306Celiac disease (PheCode 557.1)GCST900441581.45
5307Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T426ECGU0004261.45
5308Irritable bowel syndromeFING000007021.45
5309IDP dMRI ProbtrackX ICVF slf rGCST900043971.45
5310FADD/LACTB2 ratioGCST903147671.45
5311Cholesterol to Total Lipids in Large LDL percentageGCST904979381.44
5312Free Cholesterol to Total Lipids in Medium HDL percentageGCST904985831.44
5313EDAR/ERBIN ratioGCST903145751.44
5314Ever highly irritable/argumentative for 2 days | Mental healthUKBB000002191.44
5315Cholesteryl esters to total lipids ratio in very large HDLGCST900930071.44
5316CD163/ICAM1 ratioGCST903137351.44
5317rfMRI connectivity (ICA100 edge 951)GCST900058041.44
5318Vanillylmandelate (VMA) levelsGCST902003091.44
5319Pregnancy with abortive outcomeFING000012051.44
5320Platelet count during second trimester of pregnancyGCST903022251.43
5321DTI autoptx L2 slf l tractGCST903851871.43
5322PON3 levelsGCST904702871.43
5323GDNF levelsGCST902747921.43
5324Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T463ECGA0004631.43
5325T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 85)GCST903209041.43
5326Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905025701.42
5327ENO2/HCLS1 ratioGCST903146601.42
5328Left hippocampal volumeGCST902679521.42
5329Omega-6 fatty acids levelsGCST904991701.42
5330IDP dMRI TBSS ICVF Cingulum hippocampus LGCST900043641.42
5331Total lipids in small LDLGCST904996521.42
5332Bicarbonate (maximum, inv-norm transformed)GCST904751451.42
5333Right-hemisphere dorsal attention network to right-hemisphere default mode network white-matter structural connectivityGCST903028051.41
5334High light scatter reticulocyte countGCST0046111.41
5335LHPP levelsGCST904697681.41
5336wg lh intensity-contrast entorhinalGCST900037971.41
5337HYOU1 levelsGCST904694961.41
5338TNFRSF11B levelsGCST904709031.41
5339HippSubfield lh volume Whole-hippocampal-headGCST900026881.40
5340INHBC levelsGCST904696151.40
5341Systolic blood pressureGCST904727821.40
5342hematocrit (mean, inv-norm transformed)GCST904753411.40
5343Risk taking (standard GWA)GCST902672981.40
5344DTI autoptx L3 ifo l tractGCST903852051.40
5345Triglycerides to Total Lipids in Medium VLDL percentageGCST904990691.40
5346Phosphatidylcholine-O_36:2_[M+H]1+/Phosphatidylcholine-P_36:1_[M+H]1+/Phosphatidylethanolamine-P_39:1_[M+H]1+ levelsGCST900603261.40
5347Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T284ECGU0002841.40
5348Drive faster than motorway speed limit | Physical activityUKBB000001941.40
5349Phospholipids to total lipids in large VLDL percentage (UKB data field 23589)GCST902696861.40
5350BCAM/LGALS4 ratioGCST903134731.40
5351Kynurenine levelsGCST902434771.40
5352ITGB1BP2/STAT5B ratioGCST903152201.40
5353Phospholipids to total lipids ratio in large VLDLGCST900928771.40
5354SGSH levelsGCST904706151.39
5355BIN2/EREG ratioGCST903135031.39
5356aseg rh intensity Cerebellum-CortexGCST900037811.39
5357CIAPIN1 levelsGCST904687531.39
5358CRADD/FKBP4 ratioGCST903142381.39
5359X-16087 levelsGCST902005371.39
5360ITGB1/NCAM1 ratioGCST903152271.39
5361Cancer of liver and intrahepatic bile duct (PheCode 155)GCST904755681.39
5362Phospholipids in medium LDLGCST904988321.39
5363CYTL1 levelsGCST904689401.39
5364T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 3)GCST903205661.38
5365Diabetes, insulin treatment (Kela reimbursement) (more control exclusions)FING000004101.38
5366IDP dMRI TBSS L1 External capsule RGCST900041071.38
5367ICD10 O14: Pre-eclampsiaGCST904542331.38
5368wg lh intensity-contrast medialorbitofrontalGCST900038051.38
5369T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 65)GCST903208841.38
5370T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 60)GCST903206231.38
5371CLEC4G/KEL ratioGCST903141191.38
5372Major depressive disorder (ICD-10 coded)GCST0059031.38
5373Total testosterone levelsGCST902398191.38
5374GlaucomaGCST904758691.38
5375Free cholesterol in very small VLDL (UKB data field 23521)GCST902696181.38
5376CXCL11/CXCL13 ratioGCST903143331.37
5377IGSF3 levelsGCST904695391.37
5378IDP dMRI TBSS FA Posterior limb of internal capsule LGCST900038961.37
5379NXPH3 levelsGCST904701121.37
5380CTF1 levelsGCST904689011.37
5381IDP dMRI ProbtrackX FA str lGCST900039481.37
5382ABHD14B/SCRN1 ratioGCST903131451.37
5383Osteomyelitis, periostitis, and other infections involving bone (PheCode 710)GCST904762201.37
5384Total lipids in VLDL (UKB data field 23424)GCST902695211.37
5385DTI TBSS MD FornixGCST903845771.37
5386Total cholesterol levels in HDLGCST901326811.37
5387aparc-Desikan rh area precentralGCST900031301.36
5388WARS levelsGCST904710661.36
5389Prostate cancerGCST902747161.36
5390Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T410ECGA0004101.36
5391CD4 levelsGCST904686361.36
5392CTRB1/PLA2G1B ratioGCST903143071.36
5393Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T376ECGU0003761.36
5394TIRAP levelsGCST902430321.36
5395Left-hemisphere default mode network to right-hemisphere visual network white-matter structural connectivityGCST903027601.36
5396Cholesterol in very small VLDL (UKB data field 23519)GCST902696161.36
5397aparc-pial lh area precuneusGCST900031651.36
5398CD34 levelsGCST904686261.35
5399ACVRL1/TNFRSF10B ratioGCST903131581.35
5400Free Cholesterol to Total Lipids in Small LDL percentageGCST904996351.35
5401Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T456ECGU0004561.35
5402Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T404ECGA0004041.35
5403Average diameter for VLDL particles (UKB data field 23431)GCST902695281.35
5404GP5 levelsGCST904693831.35
5405Total free cholesterol levelsGCST905000631.35
5406TNFRSF12A levelsGCST904709041.35
5407Total triglycerides levelsGCST905001401.34
5408CPA1 levelsGCST904688361.34
5409TMPRSS15 levelsGCST904708921.34
5410Cellulitis and abscess of leg, except foot (PheCode 681.5)GCST904761661.34
5411Triacylglycerol_46:4_[M+NH4]1+ levelsGCST900603621.34
5412Intrinsic epigenetic age accelerationGCST900142901.34
5413GYS1/TIA1 ratioGCST903150041.34
5414PSMG3 levelsGCST904703621.34
5415Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T462ECGA0004621.34
5416DNA methylation GrimAge accelerationGCST900142881.34
5417TIA1/USP8 ratioGCST903159201.34
5418CD163/DSC2 ratioGCST903137331.34
5419Smoking/smokers in household | SmokingUKBB000007831.34
5420Secondary thrombocytopenia (PheCode 287.32)GCST904758101.33
5421wg rh intensity-contrast parsorbitalisGCST900038451.33
5422Retinal detachment with retinal defect | sense organsUKBB000007541.33
5423Heart rate variability (corrected root mean square of successive differences)GCST902812641.33
5424Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T408ECGA0004081.33
5425CLEC14A/EPHB4 ratioGCST903140791.33
5426IDP dMRI TBSS ICVF Anterior limb of internal capsule LGCST900043441.33
5427Right-hemisphere somatomotor network to thalamus white-matter structural connectivityGCST903027941.33
54283,4-dihydroxybutyrate levelsGCST901998161.33
5429Glaucoma (primary open-angle)GCST900117681.33
5430F-strong vegetable liking (derived food-liking factor)GCST900948521.33
5431Cardiovascular delta age (difference between cardiac MRI-predicted and chronological age)GCST902397481.33
5432IDP dMRI TBSS ICVF Fornix cres+Stria terminalis RGCST900043651.33
5433Docosahexaenoic acid levelsGCST904972561.33
5434Tyrosine levelsGCST902004271.33
5435Total lipid levels in IDLGCST900928371.33
5436Concentration of medium LDL particlesGCST900929111.33
5437Plasma glycocholenate sulfate* levels in chronic kidney diseaseGCST902652911.32
5438Volume of left lateral nucleusGCST904749731.32
5439ELOA/POLR2F ratioGCST903146431.32
5440High light scatter reticulocyte percentage of red cellsGCST0046121.32
5441CEACAM1 levelsGCST904686921.32
5442Corneal resistance factorGCST903086821.32
5443aseg lh volume Accumbens-areaGCST900026261.32
5444CKAP4/IL4R ratioGCST903140721.32
5445Ischemic heart disease (PheCode 411)GCST0083701.32
5446Triacylglycerol_53:3_[M+NH4]1+ levelsGCST900605281.32
5447FXN/TRIAP1 ratioGCST903148991.32
5448Clinical LDL cholesterol levelsGCST904972191.32
5449Prescriptions - calcium channel blocker|dihydropyridine|anti-hypertensiveUKBB000006731.32
5450CCL16 levelsGCST901792431.32
5451CLIP2/DNAJA2 ratioGCST903141271.31
5452T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 72)GCST903208911.31
5453BCAM/ICAM4 ratioGCST903134721.31
5454IDP dMRI TBSS OD Superior fronto-occipital fasciculus LGCST900044451.31
5455Hypertensive chronic kidney disease (PheCode 401.22)GCST904759271.31
5456FST levelsGCST900120801.31
5457FUT3 levelsGCST902412161.31
5458REST UKBBICA NODEamps25 0014GCST903854971.31
5459CD300LG levelsGCST904686231.31
5460T1 FreeSurfer aseg MaskVol-to-eTIVGCST903841921.31
5461Non-cancer illness code, self-reported - diabetes | Medical conditionsUKBB000005081.31
5462Phosphatidylcholine-O_34:2_[M+H]1+/Phosphatidylcholine-P_34:1_[M+H]1+/Phosphatidylethanolamine-O_37:2_[M+H]1+ levelsGCST900602801.31
5463CKB levelsGCST904687591.31
5464Nontoxic diffuse goitreFING000008861.31
5465Concentration of very small VLDL particlesGCST900930351.31
5466Glucose levels (UKB data field 23470)GCST902695671.30
5467Cholesteryl esters to total lipids ratio in medium LDLGCST900929071.30
5468rfMRI connectivity (ICA100 edge 931)GCST900057841.30
5469COPD-related respiratory insufficiencyFING000003521.30
5470Triglyceride levels in very small VLDLGCST900930381.30
5471Atrial fibrillation and flutter | Other forms of heart diseaseUKBB000000561.30
5472Left-hemisphere limbic network to amygdala white-matter structural connectivityGCST903027411.30
5473DBNL/HEXIM1 ratioGCST903144171.30
5474Cake icing likingGCST900947231.30
5475MAP3K5/ZBTB16 ratioGCST903153801.30
5476Impacted cerumen (PheCode 380.4)GCST904759011.30
5477Cholesteryl Esters to Total Lipids in Large VLDL percentageGCST904981651.30
5478MME levelsGCST904699141.30
5479Triacylglycerol_53:5_[M+NH4]1+ levelsGCST900605201.29
5480Urinary albumin-to-creatinine ratioGCST0096401.29
5481Phospholipid levels in IDLGCST900928391.29
5482Retinal detachments and defects | sense organsUKBB000007561.29
5483AHSP/HMBS ratioGCST903132171.29
5484Diacylglycerol_42:7_[M+H-H2O]1+ levelsGCST900602261.29
5485Atrial fibrillation and flutter | circulatory systemUKBB000000551.29
5486Right-hemisphere somatomotor network to caudate white-matter structural connectivityGCST903027951.29
5487PRKRA levelsGCST904703311.28
5488CCL11 levelsGCST902747641.28
5489Alcohol intake versus 10 years previously | AlcoholUKBB000000241.28
5490Abdominal aortic aneurysm (AAA)FING000000011.28
5491Ischemic strokeGCST0069081.28
5492Ever SmokerFING000005221.28
5493Inpatient record format - UK HES In Patient (2015 format) | Summary AdministrationUKBB000003641.28
5494Duration screen displayed | Prospective memoryUKBB000002011.28
5495Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T407ECGA0004071.28
5496DOK2/PDLIM7 ratioGCST903145351.27
5497Chronic renal failure [CKD] (PheCode 585.3)GCST904761231.27
5498SCGB1A1 levelsGCST904705401.27
5499Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T395ECGA0003951.27
5500IDP T1 FIRST left pallidum volumeGCST900024421.27
5501NMNAT1 levelsGCST904700571.27
5502DAB2/ZBTB16 ratioGCST903143701.27
5503Calculus of kidney and ureterFING000002361.26
5504Cholesteryl Esters to Total Lipids in Small LDL percentageGCST904995951.26
5505DTI TBSS MD Anterior limb of internal capsule LGCST903845891.26
5506Hypertension (PheCode 401)GCST904759191.26
5507Bioavailable testosterone levelsGCST900121021.26
5508RTBDN levelsGCST904705051.26
5509ROR1 levelsGCST904704921.26
5510Polyunsaturated fatty acids to saturated fatty acids ratioGCST905021681.26
5511Clonal haematopoiesis of indeterminate potential (TET2 mutation)GCST901652811.26
5512Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T474ECGA0004741.26
5513Malignant neoplasm, excluding all cancers (controls excluding all cancers)FING000007801.26
5514aparc-Desikan lh thickness GlobalMeanThicknessGCST900034451.26
5515Fresh fruit intake | DietUKBB000002721.26
5516Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T409ECGA0004091.26
5517IDP dMRI TBSS FA Anterior limb of internal capsule RGCST900038931.26
5518Right hippocampal volumeGCST902679741.26
5519Phospholipids to Total Lipids in Large LDL percentageGCST904980711.25
5520Total lipids in lipoprotein particles (UKB data field 23423)GCST902695201.25
5521Alpha angleGCST901296351.25
5522Cholesterol to total lipids in medium HDL percentage (UKB data field 23640)GCST902697371.25
5523Nonalcoholic fatty liver diseaseFING000008781.25
5524Saturated fatty acids to total fatty acids percentageGCST905026841.25
5525Telomere length (principal component 1)GCST904351441.25
5526NOTCH1 levelsGCST904700651.25
5527Atrial flutter (PheCode 427.22)GCST904759731.24
5528Chronic hepatitis B infectionGCST900185841.24
5529Disorder of skin and subcutaneous tissue NO (PheCode 689)GCST904761691.24
5530Type 1 diabetes with ophthalmic manifestations (PheCode 250.13)GCST904756631.24
5531CAG-177 abundance in stoolGCST900322611.24
5532Red blood cell countGCST900187511.24
5533IDP dMRI ProbtrackX L2 fmiGCST900042841.24
5534Cholesterol to Total Lipids in Very Small VLDL percentageGCST905007161.24
5535Duration walking for pleasure | Physical activityUKBB000002031.24
5536CEP85 levelsGCST904687161.24
5537Other disorders of glucose regulation and pancreatic internal secretionFING000010281.24
5538aparc-a2009s rh thickness G-postcentralGCST900037041.24
5539MMP12 levelsGCST904699161.24
5540FABP1/RBP2 ratioGCST903147531.24
5541Lung cancerGCST900118121.24
5542Triglycerides to total lipids ratio in small HDLGCST900929551.23
5543MB levelsGCST904698691.23
5544ARL13B levelsGCST904683631.23
5545ESAM/TGFB1 ratioGCST903147181.23
5546Disorders of other endocrine glandsFING000004501.23
5547CLEC14A/PTPRS ratioGCST903140811.23
5548Metabolic syndromeGCST904444871.23
5549MATN3 levelsGCST904698651.23
5550JAM2/TNFRSF19 ratioGCST903152411.23
5551PCDHB15 levelsGCST904701731.23
5552Neutrophill count | Blood countUKBB000004971.23
5553MARCO levelsGCST904698611.23
5554Fatty acid(20:3)_[M-H]1- levelsGCST900601171.22
5555aparc-a2009s lh volume S-precentral-sup-partGCST900029931.22
5556Cholesterol levels in medium VLDLGCST900929161.22
5557EGLN1/PSIP1 ratioGCST903146201.22
5558GLOD4/MIF ratioGCST903149391.22
5559aparc-pial lh area superiorparietalGCST900031691.22
5560MOG/RTBDN ratioGCST903154761.22
5561Total lipids in very large VLDLGCST905006071.22
5562HSPG2 levelsGCST904694911.22
5563C-reactive protein levels (UKB data field 30710)GCST904680641.22
5564Right-hemisphere somatomotor network to pallidum white-matter structural connectivityGCST903027971.22
5565UBE2L6 levelsGCST904710011.21
5566FN1 levelsGCST904692551.21
5567T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 112)GCST903209311.21
5568Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)FING000007701.21
5569FBP1/GSTA1 ratioGCST903147861.21
5570Triglycerides in small HDL (UKB data field 23578)GCST902696751.21
5571AGER levelsGCST904682521.21
5572DTI autoptx L3 atr l tractGCST903851951.21
5573Dry age-related macular degeneration (includes geographic atrophy)FING000004801.21
5574Acute appendicitis, no complicationsFING000000181.21
5575Sulcal opening distance of the right calloso-marginal posterior fissureGCST901049461.21
5576Left-hemisphere control network to accumbens white-matter structural connectivityGCST903027581.21
5577DNAJB14 levelsGCST902409521.21
5578Omega-3 fatty acid levelsGCST905024221.21
5579Isoleucine levelsGCST900928431.20
5580XRCC4 levelsGCST904710851.20
5581CCL11/CCL2 ratioGCST903136721.20
5582PVALB levelsGCST904703931.20
5583LILRB1 levelsGCST904697761.20
5584Autorefraction - 3mm asymmetry angle (left) | EyesightUKBB000000601.20
5585A1BG levelsGCST904681851.20
5586rfMRI connectivity (ICA100 edge 659)GCST900055121.20
5587Mood swings | Mental healthUKBB000004821.20
5588Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T425ECGU0004251.20
5589ENO3 levelsGCST904691111.19
5590Basophil percentage of granulocytesGCST0046341.19
5591IDP dMRI TBSS L2 Corticospinal tract RGCST900041291.19
5592Volume of right accessory basal nucleusGCST904750091.19
5593Cholesterol in Small LDLGCST904995551.19
5594Vegetables likingGCST900948621.19
5595HGF/MMP8 ratioGCST903150551.19
5596Right-hemisphere visual network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903027771.19
5597IRF2 levelsGCST902415661.19
5598Linoleic acid levelsGCST905020041.19
5599METAP2 levelsGCST904698941.19
5600CEACAM8/PGLYRP1 ratioGCST903140031.19
5601PTPN1/SCAMP3 ratioGCST903157431.19
5602aparc-DKTatlas lh area precentralGCST900032561.19
5603GGT1/IL1RL2 ratioGCST903149291.19
5604APRT levelsGCST904683451.19
5605T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 127)GCST903206901.18
5606Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T458ECGA0004581.18
5607Primary angle-closure glaucoma (PheCode 365.2)GCST904758761.18
5608Free Cholesterol to Total Lipids in Small HDL percentageGCST904994311.18
5609BAIAP2 levelsGCST904684191.18
5610Ischemic Heart Disease | circulatory systemUKBB000003811.18
5611Medication use (antithrombotic agents)GCST900187621.18
5612MAVS/SCAMP3 ratioGCST903153961.18
5613Urine X-24796 levels in chronic kidney diseaseGCST902668001.18
5614Fracture of rib(s), sternum and thoracic spineFING000005581.18
5615TBCC levelsGCST904708141.18
5616Cholesteryl Esters to Total Lipids in Medium LDL percentageGCST904987471.18
5617Elevated prostate specific antigen [PSA] (PheCode 796)GCST904762771.18
5618DLL1/IL18BP ratioGCST903144951.18
5619Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T402ECGU0004021.18
5620Current tobacco smoking | SmokingUKBB000001611.18
5621SH2D1A levelsGCST904706171.17
5622PM20D1 levelsGCST904702681.17
5623EDAR/PSRC1 ratioGCST903145841.17
5624IDP dMRI TBSS ICVF Tapetum RGCST900043731.17
5625DPP6/SEZ6L ratioGCST903145441.17
5626Added salt consumptionGCST901330011.17
5627TGFBR2/THBD ratioGCST903159161.17
5628aparc-Desikan rh volume precuneusGCST900028251.17
5629Hypothyroidism, drug reimbursementFING000006551.17
5630ECM1 levelsGCST904690651.17
5631Concentration of very large VLDL particlesGCST905006281.17
5632PDGFA/SPARC ratioGCST903156201.17
5633Restless legs syndromeGCST904353871.17
5634Polyunsaturated fatty acid levelsGCST905026221.17
5635IDP dMRI TBSS MD Inferior cerebellar peduncle LGCST900040381.17
5636CCN3 levelsGCST904685891.17
5637Completion of the aide-memoireGCST900127931.17
5638EDAR/IRAK4 ratioGCST903145791.16
5639NFU1 levelsGCST904700401.16
5640Phospholipids to Total Lipids in Small LDL percentageGCST904997001.16
5641Wears glasses or contact lenses (UKB data field 2207)GCST900428751.16
5642CLEC1B/DKK1 ratioGCST903140881.16
5643Incisional hernia (PheCode 550.6)GCST904760641.16
5644Type 1 diabetes with neurological manifestations (PheCode 250.14)GCST904756641.16
5645CHMP1A/RHOC ratioGCST903140531.16
5646LAYN/ULBP2 ratioGCST903152921.15
5647Alzheimer's disease (MTAG)GCST904490581.15
5648IDP T1 FIRST left putamen volumeGCST900024401.15
5649Total Lipids in Medium LDLGCST904988061.15
5650Other disorders of eyelidFING000010261.15
5651Acceptance of an invitation to participate in a mental health questionnaireGCST900127921.15
5652Concentration of IDL particlesGCST904976061.15
5653Own or rent accommodation lived in - Rent - from local authority, local council, housing association | HouseholdUKBB000006241.15
5654Leisure/social activities - Other group activity | Social supportUKBB000004001.15
5655APP/CCL28 ratioGCST903133171.15
5656Degree of unsaturationGCST905022251.14
5657Systolic blood pressure (BMI adjusted)GCST903351631.14
5658DAG1 levelsGCST904689431.14
5659GAL/PM20D1 ratioGCST903149171.14
5660IDP T1 FAST ROIs R ventral striatumGCST900025601.14
5661TOP1 levelsGCST904709331.14
5662CRKL/FIS1 ratioGCST903142661.14
5663Sphingomyelin_42:2_[M+H]1+ levelsGCST900604031.14
5664Intended management of patient (recoded) - One or more nights hospital stay | Summary AdministrationUKBB000003671.14
5665Blood cell traits latent factor 7 (white cell)GCST905592491.14
5666ENO2/ITGB1BP2 ratioGCST903146611.14
5667Mosaic chromosomal alteration of the X chromosomeGCST901652871.14
5668RGMA levelsGCST904704631.14
5669X-23641 levelsGCST902006031.13
5670Brain age gapGCST905580341.13
5671Free cholesterol levels in IDLGCST900928351.13
5672Triglyceride levels in medium LDLGCST900929141.13
5673Triglycerides to Total Lipids in Very Small VLDL percentageGCST905008861.13
5674Exposure to tobacco smoke outside home | SmokingUKBB000002291.13
5675Sphingomyelin_41:2_[M+H]1+ levelsGCST900603831.13
5676Frequency of light DIY in last 4 weeks | Physical activityUKBB000002641.13
5677Volume of right lateral nucleusGCST904750341.13
5678Saturated fatty acid levelsGCST900929801.13
5679Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T379ECGU0003791.13
5680PAK4 levelsGCST904701501.13
5681Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T483ECGU0004831.13
5682IDP dMRI ProbtrackX MD fmiGCST900042301.13
5683NAGPA levelsGCST902420041.13
5684NCS1/NPY ratioGCST903155271.12
5685Deep endometriosisFING000003821.12
5686Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T15ECGA0000151.12
5687Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T160ECGU0001601.12
5688EIF4EBP1 levelsGCST904690951.12
5689Triglyceride levels in LDLGCST900928901.12
5690T1 FreeSurfer DK rh pericalcarine areaGCST903857091.12
5691CLPS levelsGCST904687861.12
5692Cholesteryl ester levels in very small VLDLGCST900930301.12
5693Left-hemisphere dorsal attention network to right-hemisphere somatomotor network white-matter structural connectivityGCST903026951.12
5694Triglyceride to phosphoglyceride ratioGCST904999961.11
5695Free cholesterol in large VLDLGCST904981811.11
5696TJAP1 levelsGCST904708741.11
5697rfMRI amplitudes (ICA100 node 45)GCST900046331.11
5698Cholesterol in large VLDL (UKB data field 23498)GCST902695951.11
5699CD1C/CD207 ratioGCST903137451.11
5700Diverticular disease of intestineFING000004711.11
5701STK24/TDRKH ratioGCST903158931.11
5702Acute alcohol intoxication, ICD10FING000000151.11
5703ARHGEF5 levelsGCST904683601.11
5704DAB2/FKBP5 ratioGCST903143631.10
5705Smoking status - Current | SmokingUKBB000007791.10
5706AMOT levelsGCST904682951.10
5707COL15A1 levelsGCST904688111.10
5708Red cell distribution widthGCST0046211.10
5709Cholesteryl esters to total lipids ratio in large HDLGCST900928471.10
5710Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T188ECGU0001881.10
5711OCLN levelsGCST904701141.09
5712Amyotrophic lateral sclerosisGCST900271641.09
5713Other maternal disorders predominantly related to pregnancyFING000010691.09
5714DFFA levelsGCST904689871.09
5715F3 levelsGCST904691701.09
5716Total fatty acid levelsGCST905027221.09
5717Cholesteryl esters in very large VLDL (UKB data field 23492)GCST902695891.09
5718Recent trouble relaxing | AnxietyUKBB000007451.09
5719Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T186ECGA0001861.09
5720Alzheimer's disease (late onset)GCST0022451.09
5721Chronic sputum productionGCST902699021.09
5722IL6ST levelsGCST904696031.09
5723aseg global volume SupraTentorialGCST900025951.08
5724T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 42)GCST903206051.08
5725Alzheimer's disease (MTAG)GCST904490531.08
5726ADAM9 levelsGCST904682211.08
5727CPM/LAMP2 ratioGCST903142151.08
5728DTI TBSS L2 Anterior corona radiata LGCST903844991.08
5729NFKBIE levelsGCST904700391.08
5730EDAR/LAT2 ratioGCST903145821.08
5731Phlebitis and thrombophlebitis (PheCode 451)GCST904760031.08
5732Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T189ECGU0001891.08
5733Pain in thoracic spineFING000011391.08
5734MAN2B2 levelsGCST904698441.08
5735TNFRSF10A levelsGCST904708991.08
5736SIGLEC7 levelsGCST904706351.08
5737Encounter for long-term (current) use of anticoagulants (PheCode 286.2)GCST904757991.08
5738Bread type: White (UKB data field 1448_1)GCST901329641.07
5739FKBP7 levelsGCST904692451.07
5740Total lipid levels in very small VLDLGCST900930341.07
5741ALCAM levelsGCST904682791.07
5742TNFSF11 levelsGCST900120441.07
5743aseg rh intensity Accumbens-areaGCST900037881.07
5744Phospholipids to total lipids ratio in medium LDLGCST900929131.07
5745NRSN1 levelsGCST902420621.07
5746Retinal detachments and breaks | Disorders of choroid and retinaUKBB000007551.07
5747Congenital malformations of ovaries, fallopian tubes and broad ligamentsFING000003371.06
5748CNTN5/ROBO2 ratioGCST903141661.06
5749MPHOSPH8/USP8 ratioGCST903154791.06
5750Total bile acid levels in pregnancyGCST904541981.06
5751APPL2 levelsGCST904683431.06
5752aparc-a2009s lh volume G-precuneusGCST900029541.06
5753Cholesterol levels (UKB data field 30690)GCST904680661.06
5754MAP2K6 levelsGCST904698521.06
5755ADAMTSL4 levelsGCST904682291.06
5756Umbilical hernia (PheCode 550.4)GCST904760621.05
5757Able to confide | Social supportUKBB000000041.05
5758CRH levelsGCST904688621.05
5759PLTP levelsGCST904702621.05
5760OBP2B levelsGCST904701131.05
5761IDP dMRI TBSS ICVF Anterior corona radiata RGCST900043491.05
5762Nummular dermatitisFING000008931.05
5763Other headache syndromesFING000010551.05
5764Chronic ulcer of skin, not elsewhere classifiedFING000003001.05
5765Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T175ECGU0001751.05
5766Pain (limb, back, neck, head abdominally)FING000011351.05
5767Cataract (PheCode 366)GCST900437851.04
5768Phospholipids in VLDL (UKB data field 23412)GCST902695091.04
5769PDGFB/SPARC ratioGCST903156281.04
5770Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T5ECGA0000051.04
5771Prescriptions - selective beta1 antagonist|beta blockerUKBB000006991.04
5772FKBP1B/PRDX5 ratioGCST903148331.04
5773X-21285 levelsGCST902005761.04
5774Triglyceride to HDL cholesterol ratioGCST902959531.04
5775T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 54)GCST903206171.04
5776GPI levelsGCST902412691.04
5777Strawberries likingGCST900948491.04
5778Diastolic blood pressure (BMI adjusted)GCST903351651.04
5779Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T181ECGA0001811.04
5780ACE2 levelsGCST904681971.04
5781Usual walking pace | Physical activityUKBB000008911.04
5782Retinal detachments and breaksFING000012601.04
5783Other and unspecified urticariaFING000009571.04
5784Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T400ECGA0004001.04
5785N-palmitoyl-heptadecasphingosine (d17:1/16:0) levelsGCST902001151.03
5786F10 levelsGCST904691631.03
5787ICD10 O13: Gestational hypertensionGCST904542321.03
5788Body mass indexGCST901037511.03
5789T1 CAT volume L IXGCST903841331.03
5790aparc-pial rh area caudalmiddlefrontalGCST900031771.03
57911-palmitoyl-2-oleoyl-GPE (16:0/18:1) metabolite levelGCST906164031.03
5792Nonspecific chest pain | circulatory systemUKBB000005271.03
5793HDL x anxiety interaction (2df test)GCST905706651.03
5794FGF2 levelsGCST904692241.03
5795SCGB3A1 levelsGCST904705421.03
5796TEK levelsGCST904708291.03
5797Urine N-acetyl-cadaverine levels in chronic kidney diseaseGCST902655411.03
5798T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 75)GCST903208941.02
5799SERPIND1 levelsGCST904705951.02
5800Total lipid levels in lipoprotein particlesGCST900929891.02
5801RadiculopathyFING000012381.02
5802Soya milk likingGCST900948451.02
5803PEAR1 levelsGCST904702041.02
5804Direct low density lipoprotein levels (UKB data field 30780)GCST904680801.02
5805Frailty (General Factor)GCST906240461.02
5806CEP43/WASF1 ratioGCST903140231.02
5807Operation code - caesarean section / caesarian section | OperationsUKBB000005521.02
5808SEMA3G levelsGCST904705711.02
5809Triglycerides to total lipids ratio in chylomicrons and extremely large VLDLGCST900930511.02
5810CD200 levelsGCST904686061.02
5811Cardiovascular diseaseGCST900860571.02
5812Pollock likingGCST900948131.01
5813Right-hemisphere somatomotor network to hippocampus white-matter structural connectivityGCST903027981.01
5814wg rh intensity-contrast superiortemporalGCST900038561.01
5815CD300C/NBL1 ratioGCST903137921.01
5816Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T190ECGU0001901.01
5817EGFR levelsGCST904690851.01
5818RRM2B levelsGCST904705001.01
5819SPINK5/SPINT1 ratioGCST903158771.01
5820Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T187ECGA0001871.01
5821Pulmonary embolismFING000012281.01
5822Phosphatidylethanolamine (18:0_18:1) levelsGCST900249771.01
5823IDP T1 SIENAX brain-unnormalised volumeGCST900024351.01
5824Left-hemisphere default mode network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903027631.00
5825MAVS levelsGCST904698661.00
5826Intraocular pressure (confirmatory factor analysis Factor 26)GCST903093601.00
5827LRRC25 levelsGCST904698011.00
5828Chronic obstructive pulmonary disease x current smoker interaction (main effect)GCST900165911.00
5829AZU1/CEACAM8 ratioGCST903134241.00
5830DTI autoptx MD fma tractGCST903852301.00
5831Heart attackGCST904752110.99
5832IGFBP7 levelsGCST904695320.99
5833Pain in joint (PheCode 745)GCST904762620.99
5834F-cooking flavour liking (derived food-liking factor)GCST900947420.99
5835AXIN1/INPPL1 ratioGCST903134100.99
5836LGALS1 levelsGCST904697590.99
5837DTI TBSS FA Sagittal stratum LGCST903844110.99
5838Acetate levelsGCST900928030.99
5839KHK levelsGCST904696750.99
5840Cholesterol levels in very small VLDLGCST900930280.99
5841aparc-a2009s lh volume G-front-inf-OpercularGCST900029360.99
5842Testosterone levelsGCST904834860.99
5843PTPRC levelsGCST904703800.99
5844TNFRSF13B/TNFRSF13C ratioGCST903159310.99
5845Concentration of VLDL particles (UKB data field 23428)GCST902695250.98
5846CD27/ICAM3 ratioGCST903137730.98
5847Main speciality of consultant (recoded) - Trauma and orthopaedics | Summary AdministrationUKBB000004200.98
5848Irritable bowel syndrome mixed subtypeGCST902439590.98
5849ChronotypeGCST0038370.98
5850Total lipid levels in VLDLGCST900929990.98
5851Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T8ECGA0000080.98
5852Cholesteryl Esters to Total Lipids in Small HDL percentageGCST904994030.98
5853MARS1 levelsGCST904698620.98
5854Volume of left central nucleusGCST904749580.98
5855Dried fruit intake | DietUKBB000001930.98
5856DTI TBSS L2 Anterior corona radiata RGCST903844980.98
5857Volume of right medial nucleusGCST904750450.98
5858DKK1/SERPINE1 ratioGCST903144800.98
5859Total free cholesterol levelsGCST900929880.98
5860PCOLCE levelsGCST904701750.98
5861Valine levelsGCST905001760.98
5862FGF21 levelsGCST904692220.98
5863Principal component-derived dietary pattern 31GCST901330360.97
5864ICAM1/REG1A ratioGCST903151140.97
5865Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T403ECGA0004030.97
5866Takes medication for prostate cancer?GCST904751870.97
5867UNC5D levelsGCST904710100.97
5868RND3 levelsGCST904222300.97
5869STK11 levelsGCST904707650.97
5870Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T394ECGA0003940.97
5871Linoleic acid levelsGCST905020120.97
5872Morning/evening person (chronotype) | SleepUKBB000004830.97
5873HippSubfield rh volume subiculum-headGCST900026930.97
5874Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T224ECGU0002240.96
5875Glycerophosphorylcholine (GPC) levelsGCST901996290.96
5876Free cholesterol to total lipids ratio in large HDLGCST900928490.96
5877Chronic obstructive pulmonary disease in non-current smokersGCST900165940.96
5878Eosinophil percentage of white cells varianceGCST905656900.96
5879CXCL17/SFTPA2 ratioGCST903143410.96
5880Hippocampal right HATA volumeGCST902679690.96
5881MYOC levelsGCST904699830.96
5882IGDCC4 levelsGCST904695230.96
5883Urine 5-acetylamino-6-amino-3-methyluracil levels in chronic kidney diseaseGCST902646740.95
5884Biliary cirrhosis, NASFING000002130.95
5885Bread type - White | DietUKBB000001060.95
5886Glomerular filtration rate (cystatin C)GCST0033750.95
5887IDP dMRI TBSS ICVF Genu of corpus callosumGCST900043290.95
5888TST levelsGCST904709820.95
5889IGFBPL1 levelsGCST901793230.95
5890GLT25D1 levelsGCST904264210.95
5891aparc-a2009s rh area G-precentralGCST900033990.95
5892Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T9ECGA0000090.95
5893Urine X-23518 levels in chronic kidney diseaseGCST902665950.95
5894aparc-Desikan lh thickness precentralGCST900034680.95
5895Phospholipids to total lipids ratio in medium HDLGCST900929010.95
5896PollinosisGCST900186830.95
5897Left-hemisphere visual network to right-hemisphere limbic network white-matter structural connectivityGCST903026590.95
5898Ovarian cystFING000011320.95
5899T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 33)GCST903205960.94
5900Autorefraction - 3mm strong meridian angle (left) | EyesightUKBB000000670.94
5901Mood [affective] disordersFING000008360.94
5902Disorders of vestibular function (Vertigo)FING000004640.94
5903Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)FING000007660.94
5904Total Lipids in HDLGCST904974010.94
5905T1 FreeSurfer aseg Left-CaudateGCST903841440.94
5906SIGLEC5 levelsGCST904706330.94
5907Triglycerides in large VLDLGCST904982800.94
5908Urine glycocholenate sulfate* levels in chronic kidney diseaseGCST902652920.94
5909X-13671 levelsGCST902438290.94
5910CXCL16 levelsGCST902405240.94
5911Phenylalanine levels (UKB data field 23468)GCST902695650.94
5912VMO1 levelsGCST904710420.93
5913aseg rh volume CerebralWhiteMatterGCST900026320.93
5914Volume of left medial nucleusGCST904748920.93
5915Biological Grandparent (paternal): Diabetes / SugarGCST904755490.93
5916Polyunsaturated fatty acid levelsGCST905021400.93
5917Cholesterol to Total Lipids in Small HDL percentageGCST904993690.93
5918aparc-Desikan rh area superiorparietalGCST900031350.93
5919IL27 levelsGCST900120170.93
5920Sphingomyelin levelsGCST900929820.93
5921CXCL11 levelsGCST904689240.93
5922IRAK4/VASH1 ratioGCST903152010.93
5923BA-exvivo lh thickness BA2GCST900035140.93
5924Cholesteryl ester levels in chylomicrons and extremely large VLDLGCST905009430.93
5925hemoglobin (maximum, inv-norm transformed)GCST904753720.93
5926CXCL5/MESD ratioGCST903143500.93
5927Concentration of medium HDL particles (UKB data field 23565)GCST902696620.93
5928ACP5 levelsGCST904682030.93
5929red cell diameter width (RDW, maximum, inv-norm transformed)GCST904763570.93
5930CALCOCO2 levelsGCST904685310.93
5931Autorefraction - 6mm asymmetry index (left) | EyesightUKBB000000730.93
5932aparc-a2009s rh area G-precuneusGCST900034000.92
5933Triglyceride levels in IDLGCST900928410.92
5934Triglyceride levels in chylomicrons and extremely large VLDLGCST901326300.92
5935Total concentration of lipoprotein particlesGCST905001010.92
5936ERBB2/GUSB ratioGCST903146870.92
5937CNDP1 levelsGCST904687960.92
5938ACVRL1/EFNA4 ratioGCST903131560.92
5939Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T283ECGU0002830.92
5940ARF6 levelsGCST904683480.92
5941TRIM40 levelsGCST904709680.92
5942Mean arterial pressure (BMI adjusted)GCST903351690.92
5943APEX1/LSP1 ratioGCST903133070.92
5944T1 FreeSurfer DK lh MeanThickness thicknessGCST903856560.92
5945Cholesteryl ester levels in medium VLDLGCST900929180.92
5946Arterial stiffness indexGCST0084030.91
5947IDP dMRI ProbtrackX L3 fmiGCST900043110.91
5948IDP dMRI TBSS MD Genu of corpus callosumGCST900040290.91
5949BCAM/CDH5 ratioGCST903134690.91
5950aparc-a2009s rh thickness Pole-temporalGCST900037190.91
5951aseg global volume BrainSegNotVentSurfGCST900025920.91
5952Biological Mother: Cancer, SkinGCST904754870.91
5953VSIG2 levelsGCST904710510.91
5954aparc-Desikan rh volume superiorparietalGCST900028290.91
5955Current employment status - In paid employment or self-employed | EmploymentUKBB000001580.91
5956Type 2 diabetesGCST0101180.91
5957Mean corpuscular hemoglobin concentrationGCST900187450.91
5958BA-exvivo rh area BA4aGCST900032250.90
5959Shoulder lesionsFING000013030.90
5960CST3/TFF3 ratioGCST903142990.90
5961SEZ6L levelsGCST904706070.90
5962HippSubfield rh volume presubiculum-headGCST900026950.90
5963TRIM21 levelsGCST904709640.90
5964Gastric ulcerGCST902709270.90
5965Illnesses of siblings - Diabetes | Family historyUKBB000003500.90
5966Triglycerides in LDLGCST904984690.90
5967aseg lh number HolesBeforeFixingGCST900026300.90
5968CPB1 levelsGCST902405970.90
5969Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T402ECGA0004020.90
5970CX3CL1 levelsGCST900120740.90
5971Oral glucose tolerance test-0hGCST902977880.90
5972Triglyceride levelsGCST902786450.90
5973Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T378ECGU0003780.90
59741-linoleoyl-GPI (18:2) levelsGCST901998210.90
5975SEMA4D levelsGCST904705730.90
5976Potatoes likingGCST900948160.90
5977EndometriosisFING000004970.89
5978LTBP2/MYOC ratioGCST903153370.89
5979white blood cell count (WBC, mean, inv-norm transformed)GCST904764540.89
5980Phospholipid levels in very small VLDLGCST900930360.89
5981Frailty (Factor 1 - Limited Social Support)GCST906240470.89
5982CKMB levelsGCST904752210.89
5983Cholesterol to Total Lipids in Very Large VLDL percentageGCST905005420.89
5984FLT3LG levelsGCST904692500.89
5985Total cholesterol levelsGCST905000150.89
5986CRTAC1 levelsGCST904688700.89
5987TYRO3 levelsGCST904709970.88
5988aseg lh volume HippocampusGCST900026240.88
5989Total fatty acids levels (UKB data field 23442)GCST902695390.88
5990CPB1/CTRB1 ratioGCST903142080.88
5991aparc-DKTatlas lh thickness precentralGCST900035620.88
5992TNFRSF10C levelsGCST904709010.88
5993Ventral hernia (PheCode 550.5)GCST904760630.88
5994Other chondrocalcinosisFING000009770.88
5995BMP7 levelsGCST900881570.88
5996LYN levelsGCST904698260.88
5997Phospholipids to Total Lipids in Very Large VLDL percentageGCST905006550.88
5998RAB2B levelsGCST904704060.88
5999aseg rh intensity CaudateGCST900037830.88
6000Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T177ECGA0001770.88